Czarnecka, Anna M <br/><br/>
The use of sunitinib in renal cell carcinoma: where are we now?  [electronic resource] 

 -  Expert review of anticancer therapy  Sep 2014 
 - 983-99 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1744-8328 
<br/><br/><label>Standard No.: </label>10.1586/14737140.2014.941815  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Angiogenesis Inhibitors--adverse effects<br/>Animals<br/>Antineoplastic Agents--adverse effects<br/>Carcinoma, Renal Cell--drug therapy<br/>Disease-Free Survival<br/>Humans<br/>Indoles--adverse effects<br/>Kidney Neoplasms--drug therapy<br/>Neoplasm Metastasis<br/>Pyrroles--adverse effects<br/>Sunitinib